Fenton Mary Kay
Cullinan Therapeutics, Inc. · Chief Financial Officer
Fenton Mary Kay is listed in public filings as officer: Chief Financial Officer. This Fenton Mary Kay insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Cullinan Therapeutics, Inc. (CGEM). Investors use Fenton Mary Kay's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.7M126.4k shares | SellFeb 20, 2026 | $59.9K4.4k shares | $13.62 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.7M137.5k shares | Grant / ExerciseFeb 18, 2026 | $1.7M137.5k shares | $12.44 | -- | |
| --130.8k shares | Grant / ExerciseFeb 18, 2026 | Disclosure amount unavailable68.8k shares | -- | -- | |
| $403k62k shares | Grant / ExerciseDec 31, 2025 | $17527 shares | $6.49 | -- | |
| $1.1M120k shares | Grant / ExerciseFeb 19, 2025 | $1.1M120k shares | $9.43 | -- | |
| --60k shares | Grant / ExerciseFeb 19, 2025 | Disclosure amount unavailable60k shares | -- | -- |